Dimension Therapeutics To Participate In 3rd Annual Piper Jaffray Genomerx Symposium

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, today announced that Dimension’s CEO Annalisa Jenkins, MBBS, MRCP, will participate in a panel discussion, titled Gene Therapy: Ramping Up For Success, at the 3rd annual Piper Jaffray GenomeRx Symposium on Wednesday, May 20, 2015. The conference is taking place at The New York Palace Hotel, New York, New York, and the panel will begin at 2:30pm EDT.

Help employers find you! Check out all the jobs and post your resume.

Back to news